Leadership Overview
Vanda Pharmaceuticals has 4 executives leading key functions including corporate strategy, financial oversight, global marketing, and treasury management.
Driven by a commitment to medical innovation, Vanda Pharmaceuticals advances patient health through the application of genomics and advanced drug discovery technologies across global markets.
Driven by a commitment to medical innovation, Vanda Pharmaceuticals advances patient health through the application of genomics and advanced drug discovery technologies across global markets.
Leadership Roles at Vanda Pharmaceuticals
Mihael Polymeropoulos - President, Chief Executive Officer & Chairman
Mihael Polymeropoulos, the President, Chief Executive Officer & Chairman at Vanda Pharmaceuticals, directs the overarching strategic vision for the biopharmaceutical research and development pipeline. Overseeing the integration of genetics and genomics into drug discovery, the President, Chief Executive Officer & Chairman ensures that clinical trials align with long-term therapeutic goals. This leadership role involves constant collaboration with the Board to maintain high standards of corporate governance while expanding the company footprint across North America, Europe, and Asia. By prioritizing the development of novel therapeutic approaches, Mihael Polymeropoulos directly influences the commercial trajectory of the organization. The President, Chief Executive Officer & Chairman maintains focus on delivering innovative medicines that address unmet patient needs. Through rigorous oversight of research initiatives, the executive secures the future of the pharmaceutical portfolio, ensuring that scientific advancements translate into tangible health outcomes for patients worldwide.
Paul Jones - Chief Financial Officer
Paul Jones, the Chief Financial Officer at Vanda Pharmaceuticals, manages the fiscal health and capital allocation strategies necessary for sustained biopharmaceutical growth. Overseeing financial reporting and investor relations, the Chief Financial Officer ensures that budgetary resources support the intensive research and development cycles required for drug discovery. This leadership role involves analyzing market trends across North America and international regions to optimize resource distribution. By maintaining strict financial discipline, Paul Jones enables the company to fund complex clinical trials and advanced genomic research. The Chief Financial Officer works closely with the executive team to align operational spending with the broader mission of creating innovative medicines. Through precise financial modeling and risk assessment, the executive provides the stability needed for long-term investment in pharmaceutical innovation. Jones secures the financial foundation that allows the organization to pursue ambitious medical breakthroughs while maintaining profitability in a competitive global industry.
Kevin Moran - Senior Vice President, Chief Financial Officer and Treasurer
Kevin Moran, the Senior Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, manages the treasury functions and liquidity strategies essential for global biopharmaceutical operations. Overseeing cash management and capital structure, the Senior Vice President, Chief Financial Officer and Treasurer ensures that the company maintains the financial flexibility to support ongoing drug development and clinical research. This leadership role involves monitoring international currency fluctuations and investment portfolios across North America and overseas markets. By optimizing the balance sheet, Kevin Moran supports the strategic initiatives that define the company research agenda. The Senior Vice President, Chief Financial Officer and Treasurer works with the executive leadership to ensure that treasury policies align with the long-term growth objectives of the organization. Through diligent oversight of financial assets, the executive mitigates risk and enhances shareholder value. Moran provides the necessary financial infrastructure to sustain the development of innovative medicines and advanced therapeutic delivery systems.
Joakim Wijkstrom - Senior Vice President, Chief Marketing Officer
Joakim Wijkstrom, the Senior Vice President, Chief Marketing Officer at Vanda Pharmaceuticals, architects the commercial strategies that bring novel therapeutic products to global markets. Overseeing brand positioning and market access, the Senior Vice President, Chief Marketing Officer ensures that the value of innovative medicines reaches patients across North America, Europe, and Asia. This leadership role involves translating complex clinical data into compelling narratives for healthcare providers and stakeholders. By analyzing regional market dynamics, Joakim Wijkstrom drives the adoption of new delivery methods and pharmaceutical solutions. The Senior Vice President, Chief Marketing Officer collaborates with research teams to ensure that commercial strategies reflect the unique benefits of the company drug pipeline. Through targeted outreach and strategic partnerships, the executive expands the reach of the organization. Wijkstrom optimizes the commercialization process, ensuring that the company maintains a strong competitive position while improving patient lives through effective communication and market penetration.
Explore Leadership Teams in Manufacturing
Pfizer is a biopharmaceutical company that researches, develops, manufactures, and markets medicines and vaccines across multiple therapeutic areas. The company focuses on areas such as oncology, internal medicine, inflammation and immunology, and vaccines to help prevent, treat, and manage disease worldwide.
Company Leadership SC
SK
NA
MO
Founded in 2020, Viatris empowers people worldwide to live healthier at every stage of life. They provide access to medicines, advance sustainable operations, develop innovative solutions, and leverage their collective expertise to improve patient health. Viatris is headquartered in Canonsburg, Pennsylvania.
Company Leadership JG
ZW
PCI Pharma Services is an integrated full service provider to companies in the global healthcare industry. They offer services including analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage, and distribution. They are headquartered in Philadelphia, Pennsylvania with locations in the United States and Europe.
Company Leadership BP
LR
HL
Soft gelatin capsule products, liquid preparations, medicinal plasters, ointments, and creams are produced at the Gunung Putri Plant. In producing these products, Gunung Putri Plant implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and ISO 22000:2018 certificates. Meanwhile, sterile injection products and solid preparations in the form of tablets and capsules are produced at the Citeureup Plant. The Citeureup Plant also implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and SNI ISO/IEC 17025:2017 certificates. In running the Toll Manufacturing business, Darya-Varia collaborates with an affiliated company, PT Medifarma Laboratories, at the Cimanggis Depok Plant. The Company has been trusted by local business partners and both for the domestic and international markets for the Export & Toll Manufacturing business and conducts technology transfer, lab and pilot trials, stability studies, procurement of raw materials and packaging, and commercial production of high-quality finished goods. Darya-Varia always ensures the quality and safety of each product, so that all of its products are certified halal. All plant facilities owned by Darya-Varia have implemented the halal guarantee system. Blue Sphere Singapore Pte Ltd (BSSPL) owns 92.13% stake in Darya-Varia. For 45 years, Darya-Varia has continued to progress in providing high quality health facilities. Through the mission of "building a healthier Indonesia for everyone one person at a time", Darya-Varia is always committed to providing a variety of quality products with the right strategy for the health of the Indonesian people. DARYA VARIA
Company Leadership CH
Frequently Asked Questions Regarding Vanda Pharmaceuticals Top Executives and Leadership Team
